Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Aratana Therapeutics Company Profile (NASDAQ:PETX)

Consensus Ratings for Aratana Therapeutics (NASDAQ:PETX) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $23.00 (70.37% upside)

Analysts' Ratings History for Aratana Therapeutics (NASDAQ:PETX)
Show:
DateFirmActionRatingPrice TargetDetailsShare
10/6/2014Piper JaffrayInitiated CoverageOverweight$17.00ViewTweet This Rating  Share This Rating on StockTwits
6/6/2014Jefferies GroupReiterated RatingBuy$25.00 -> $23.00ViewTweet This Rating  Share This Rating on StockTwits
5/14/2014Stifel NicolausReiterated RatingBuy$30.00 -> $22.00ViewTweet This Rating  Share This Rating on StockTwits
3/24/2014Jefferies GroupInitiated CoverageBuy$25.00ViewTweet This Rating  Share This Rating on StockTwits
2/10/2014Stifel NicolausReiterated RatingBuy$30.00 -> $33.00ViewTweet This Rating  Share This Rating on StockTwits
2/10/2014BarclaysInitiated CoverageOverweight$30.00ViewTweet This Rating  Share This Rating on StockTwits
10/25/2013Stifel NicolausBoost Price TargetBuy$13.00 -> $33.00ViewTweet This Rating  Share This Rating on StockTwits
10/24/2013JMP SecuritiesBoost Price Target$16.00 -> $38.00ViewTweet This Rating  Share This Rating on StockTwits
10/15/2013Lazard Capital MarketsBoost Price TargetBuy$28.00 -> $39.00ViewTweet This Rating  Share This Rating on StockTwits
7/23/2013William BlairInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
7/23/2013Lazard Capital MarketsInitiated CoverageBuy$28.00ViewTweet This Rating  Share This Rating on StockTwits
7/22/2013Craig HallumInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
7/22/2013JMP SecuritiesInitiated CoverageOutperform$16.00ViewTweet This Rating  Share This Rating on StockTwits
7/22/2013Stifel NicolausInitiated CoverageBuy$13.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 11/26/2012 forward)